Actively Recruiting
Evaluating Transcranial Direct Current Stimulation for Managing Suicidal Thoughts in Adults with Treatment-Resistant Depression A Pilot Study
Led by Centre Hospitalier Henri Laborit · Updated on 2026-10-23
50
Participants Needed
2
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of transcranial direct current stimulation tDCS to reduce suicidal thoughts in adults diagnosed with depression. This pilot study focuses on patients who have treatment-resistant depression and aims to assess the effectiveness of 15 sessions of tDCS delivered daily. The study is sponsored by Centre Hospitalier Henri Laborit and seeks to understand how this device-based therapy might help manage suicidal ideation. Participants will receive active tDCS treatment consisting of 15 daily sessions, each lasting 30 minutes with a 2 mA intensity. After completing the 15 stimulation sessions, patients will attend three follow-up visits scheduled on days 19, 49, and 79 to monitor changes and progress. The treatment phase and follow-up are designed to evaluate the effect of tDCS over time. During the study, participants will undergo initial screening to confirm eligibility and provide informed consent. Researchers will assess suicidal thoughts using the Scale for Suicide Ideation SSI at baseline and on day 19 after treatment. Additional assessments include depression severity with the Montgomery and Asberg Depression Rating Scale MADRS, implicit association tests for suicidal ideation, and quality of life surveys at multiple follow-up points. The study monitors safety and treatment response throughout the study period, which extends until December 2027.
CONDITIONS
Brief Title
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
Research Team
G
Ghina Harika-Germaneau
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here